来自BM-MSCs的MMP14通过JAK/STAT通路促进急性髓性白血病的进展和Ara-C耐药性
Jinxian Wu1, Xinqi Li1, Yin Liu1
1Department of Hematology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430072, P. R. China.
Experimental hematology & oncology
|March 23, 2025
概括
介酶体 stromal 细胞 (MSCs) 通过MMP14促进急性髓性白血病 (AML) 的生长和化学抵抗. 在MSC中抑制MMP14可以通过破坏这一关键的交叉声交响来提供新的AML疗法.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 干细胞生物学 干细胞生物学
背景情况:
- 白血病干细胞 (LSCs) 和介酶体 stromal 细胞 (MSCs) 之间的交叉影响白血病的进展和治疗结果.
- 在急性髓性白血病 (AML) 中,MSC衍生的矩阵金属蛋白酶-14 (MMP14) 的特定作用仍然在很大程度上未被探索.
研究的目的:
- 调查MSC衍生的MMP14在AML发病,进展和化学抵抗中的作用.
- 阐明MSCs,特别是通过MMP14影响AML行为的机制.
主要方法:
- 对抗AML患者衍生的MSCs (AML-MSCs) 和健康的供体衍生的MSCs (HD-MSCs) 的比较.
- 基因和蛋白质表达的分析.
- 在MSC中击倒MMP14.
- 用AML细胞进行体外共同培养测定.
- 在体内白血病发生模型.
- 涉及PGE2分泌和JAK-STAT通路激活的机制研究.
- 对细胞氨酸 (Ara-C) 的化学疗法耐药性的评估.
主要成果:
- 与HD-MSC相比,AML-MSC显示出对AML细胞生长的增强支持.
- 在MSC中MMP14的敲击损害了MSC的增殖和干性.
- MSCs抑制了AML细胞的增殖和细胞循环,增加了细胞亡,从而减少了白血病的潜力.
- 通过PGE2和JAK-STAT激活,MMP14调解了肌肉结构的改变,促进了白血病的进展.
- 抑制MMP14可以降低AML细胞中MSC诱导的化学抵抗.
结论:
- 来自MSC的MMP14极大地促进了AML的进展和化学抵抗.
- 准MMP14信号通路为AML提供了一个潜在的新疗法策略.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


